Retraction notice to "Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammatin" [European Journal of Pharmaceutical Sciences 51C (2013) 26-33].
- DOI
- 10.1016/j.ejps.2018.08.039
- Published
- 2018-10-01
- Container
- Eur J Pharm Sci
- Publisher
- Not recorded
- Open access
- no
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejps.2018.08.039,
title = {Retraction notice to "Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammatin" [European Journal of Pharmaceutical Sciences 51C (2013) 26-33].},
author = {Derosa G and Cicero AFG and Carbone A and Querci F and Fogari E and D'Angelo A and Maffioli P.},
year = {2018},
journal = {Eur J Pharm Sci},
doi = {10.1016/j.ejps.2018.08.039},
url = {https://doi.org/10.1016/j.ejps.2018.08.039}
}RIS
TY - JOUR TI - Retraction notice to "Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammatin" [European Journal of Pharmaceutical Sciences 51C (2013) 26-33]. AU - Derosa G AU - Cicero AFG AU - Carbone A AU - Querci F AU - Fogari E AU - D'Angelo A AU - Maffioli P. PY - 2018 JO - Eur J Pharm Sci DO - 10.1016/j.ejps.2018.08.039 UR - https://doi.org/10.1016/j.ejps.2018.08.039 ER -
APA
G, D., AFG, C., A, C., F, Q., E, F., A, D., & P., M. (2018). Retraction notice to "Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammatin" [European Journal of Pharmaceutical Sciences 51C (2013) 26-33].. Eur J Pharm Sci. https://doi.org/10.1016/j.ejps.2018.08.039
Source records
- europe-pmc · retrieved 2026-09-26T20:34:02.629Z